Pericoronary Adipocyte Size Gradient
Direct Measurement of Pericoronary Adipocyte Size Gradient as a Parameter of Immunometabolic Changes of Perivascular Adipose Tissue
Institute for Clinical and Experimental Medicine
60 participants
Jun 1, 2023
OBSERVATIONAL
Conditions
Summary
Evaluation of pericoronary adipocyte gradient (PCAT) in relationship with local atherosclerotic changes in a patient undergoing heart transplantation.
Eligibility
Inclusion Criteria3
- Age 30-90 years
- Diagnosis of dilatational or ischemic cardiomyopathy
- Patients undergoing heart transplantation in IKEM
Exclusion Criteria4
- Known combined diagnosis of dilatational and ischemic cardiomyopathy
- Arrhythmogenic cardiomyopathy
- Congenital heart defects
- Non-eligibility due to the absence of informed consent
Interventions
The study population comprises patients who underwent heart transplantation for heart failure at the Institute for Clinical and Experimental Medicine, Cardiovascular Surgery Department, between June 2023 and December 2028. Only the subjects' retrospective clinical data and matching heart samples will be analyzed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07360925